Methadone is a full opioid agonist, meaning it activates the same receptors in the brain that heroin, fentanyl, and prescription painkillers do. But it does so slowly and steadily, producing a long, flat effect rather than the sharp high and crash of shorter-acting opioids. This is the core of how it works: it satisfies the brain’s opioid receptors enough to prevent withdrawal and reduce cravings without delivering the rush that drives addiction.
What Methadone Does in the Brain
Your brain has opioid receptors, primarily called mu receptors, that naturally respond to pain-relieving chemicals your body produces. Drugs like heroin and fentanyl flood these receptors quickly, creating an intense wave of euphoria followed by a rapid drop. Methadone binds to the same mu receptors, but because of the way it’s absorbed and distributed in the body, it reaches the brain gradually and maintains a steady presence there for much longer.
This slow onset is what makes methadone useful for treating opioid use disorder. When someone takes their daily dose, the drug builds up in body tissues and releases into the bloodstream at a consistent rate. The result is that mu receptors stay partially occupied throughout the day. This prevents the dramatic swings between feeling high and feeling sick that keep people trapped in cycles of use. It also creates a partial blocking effect: if someone uses heroin or another opioid on top of their methadone dose, the high is significantly blunted because many of the receptors are already occupied.
Why It Lasts So Long
Methadone’s half-life, the time it takes for half the drug to leave your system, averages around 24 hours but can range anywhere from 8 to 59 hours depending on the person. That’s dramatically longer than heroin (which has a half-life of minutes) or oxycodone (a few hours). This long half-life is what allows methadone to be taken just once a day for addiction treatment.
It takes about five days of consistent dosing for methadone levels in the blood to stabilize, a point called steady state. During those first days, the drug is still accumulating in the body, which is why doses are started low and increased carefully. Once steady state is reached, the person experiences a consistent level of the drug throughout the day with no peaks or valleys.
One important wrinkle: when methadone is used for pain rather than addiction, its pain-relieving effect doesn’t last as long as its other effects. Even though the drug stays in the body for a full day or more, the analgesic window is shorter, so people taking it for chronic pain often need multiple doses per day.
How the Body Breaks It Down
Methadone is processed primarily in the liver by a family of enzymes. The most important of these is called CYP2B6, followed by several others including CYP3A4 and CYP2D6. This matters for a practical reason: many common medications, supplements, and even grapefruit juice can speed up or slow down these same liver enzymes. When that happens, methadone levels in the blood can rise unexpectedly (increasing the risk of side effects) or drop too low (triggering withdrawal symptoms).
Genetic differences also play a role. Some people naturally produce more or less of these liver enzymes, which is one reason the half-life varies so widely from person to person. Two people on the same dose can end up with very different blood levels of the drug. This genetic variability, combined with potential drug interactions and factors like overall health and sex, means that methadone dosing requires careful individualized adjustment.
Combining methadone with other substances that slow breathing, such as alcohol, benzodiazepines, or other opioids, is particularly dangerous. These combinations compound the respiratory depression that methadone can cause on its own.
Dosing for Opioid Use Disorder
For addiction treatment, methadone is dispensed daily at licensed clinics (called opioid treatment programs) where patients typically drink a liquid dose under observation. Starting doses are low to avoid overdose during the accumulation phase, then gradually increased over weeks.
Most people stabilize on a maintenance dose between 60 and 120 mg per day. Research consistently shows that doses in the 80 to 100 mg range produce better treatment retention than lower doses. For people who have been using highly potent synthetic opioids like fentanyl, doses above 120 mg are sometimes needed. Treatment retention data from 2023 shows that about 61% of patients remain in treatment at 30 days and roughly 28% at six months, though these numbers vary widely across clinics. Staying in treatment is strongly linked to reduced overdose and death.
How It Compares to Buprenorphine
Buprenorphine, the other main medication for opioid use disorder, works on the same mu receptors but in a fundamentally different way. Where methadone is a full agonist that fully activates the receptor, buprenorphine is a partial agonist. Think of it like a dimmer switch versus a full light switch: buprenorphine turns the receptor partway on and then hits a ceiling. No matter how much more you take, the effect plateaus.
This ceiling effect gives buprenorphine a safety advantage. It causes less respiratory depression than methadone, making fatal overdose less likely when taken alone. However, that same weaker activation means buprenorphine is not as effective at satisfying mu receptors in people with severe opioid dependence. Clinical trials have generally shown that methadone’s stronger receptor activity produces better retention in treatment, particularly for people with heavy or long-standing opioid use. The tradeoff is that methadone requires more clinical oversight because of its higher overdose potential.
Heart Rhythm Risk
Unlike most opioids, methadone can affect the electrical activity of the heart. Specifically, it can lengthen a portion of the heartbeat cycle called the QT interval. When the QT interval stretches too long, it raises the risk of a dangerous irregular heartbeat called torsades de pointes, which can cause sudden cardiac death.
This risk increases at doses above 100 mg per day, but it can occur at lower doses too. In one review of 51 patients, about 14% had at least one dangerously prolonged QT reading, and more than half of those patients were taking less than 100 mg daily. Because of this, people starting methadone are typically given an electrocardiogram (ECG) before treatment, another about a month in, and then annually. More frequent monitoring may be needed if a new medication is added that could interact with methadone or if someone develops symptoms like dizziness or fainting.
Overdose and Naloxone Response
Methadone overdose looks like any opioid overdose: slowed or stopped breathing, pinpoint pupils, loss of consciousness. It responds to naloxone, the opioid-reversing medication available as a nasal spray or injection. But because methadone lasts so much longer in the body than naloxone does, a single dose of naloxone may not be enough. The naloxone wears off in 30 to 90 minutes, while methadone can continue suppressing breathing for hours.
This means someone who overdoses on methadone may need repeated naloxone doses or even a continuous intravenous drip of naloxone in the hospital. Patients who respond to naloxone after a methadone overdose are typically monitored for 6 to 12 hours because the overdose symptoms can return once the naloxone wears off. This extended monitoring period is one of the key practical differences between a methadone overdose and an overdose involving a shorter-acting opioid like heroin.